Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HSF1 shRNA is a research-use-only short hairpin RNA (shRNA) reagent designed to knock down the expression of heat shock transcription factor 1 (HSF1). HSF1 is a master regulator of the heat shock response and is frequently hijacked in various cancers to support cell survival, proliferation, and metastasis under proteotoxic stress. By targeting HSF1 mRNA for degradation via the RNA interference (RNAi) pathway, HSF1 shRNA is widely utilized in preclinical research to investigate the role of HSF1 in tumor progression, drug resistance, and immune evasion, such as its impact on CD8+ T cell infiltration and CCL5 expression in breast cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HSF1 shRNA.